Given that IFNγ deficiency reduced angiotensin II–induced BP elevations, these findings suggested that Sh2b3 reduces T-cell IFNγ production to limit BP elevations and end-organ damage in hypertension (Figure 2).26 This evidence concerns the gene AGT and hypertensive disorder.